Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 2007

View Archived Issues

Utility of I-123 MIBG in diagnosis of neuroblastomas

AZ-001 meets two-hour pain-relief endpoint in migraine

Topline results for CRx-139 in RA

Recent patents cover new therapeutic agents for cancer

Recent University of Dundee patent describes novel wound-healing agents

New therapeutic agents for gastrointestinal disorders reported in recent patents

New experimental data on sildenafil-doxazosin combination

INO-1001 evaluated in phase II study

BAY-68-4986 reduces heart rate in chronic angina patients

BMS-695735: a novel, improved IGF-1R inhibitor reported by BMS

ABT-888, a new PARP inhibitor, shows antitumor activity in several cancer models

Azixa studied in phase II for melanoma patients with brain metastases

AL-108 cleared for clinical study in schizophrenia-related cognitive impairment

Phase II trial evaluates belinostat with bortezomib in refractory multiple myeloma

HZT-501 begins phase II program for mild to moderate pain relief

Neugranin begins phase I/IIa study for neutropenia

United Therapeutics and Mochida sign Japanese agreement for Remodulin

CytoGenix and USAMRIID collaborate on biodefense vaccines

Phase IIb kidney transplant trial of ISA-247 clears interim review

Zyvox increases risk of death in patients with Gram-negative infections

BrainCells and Lundbeck form CNS research collaboration

Collaborative compound PS-386113 begins phase I for inflammatory disease

Phase III trial evaluates Zingo in adults

FDA accepts for review PMA for Repel-CV

Merck and Lundbeck discontinue gaboxadol development

BLA submission for Cervarix

GSK files Globorix meningococcal vaccine

E.U. approval for Xeloda for advanced stomach cancer

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...